Pigmented Lesion Treatment Market

Global Pigmented Lesion Treatment Market Size (2024 to 2029)

The size of the global pigmented lesion treatment market is anticipated to grow at a healthy growth rate from 2024 to 2029.

Current Scenario of the Global Pigmented Lesion Treatment Market

Pigmented Lesion Treatment is one of the most common skin diseases affecting the elderly population. The most frequently affected region is the face; nevertheless, marks can still emerge on other body parts. It is primarily a consequence of aging and extreme sun exposure. Other causes may include endogenous and exogenous, both malignant and aetiologies. Nowadays, various therapies, laser treatments, and medications can effectively treat and remove these marks. Introduction of non-invasive med-aesthetic systems by Pharmaceutical companies that can efficiently lessen the impact of the condition. These novel medications are reliable, safe, and comfortable.

MARKET DRIVERS

The growing aging population and rising regularity in pigmentation disorders primarily heighten the global pigmented lesion treatment Market growth

The growing demand for the cure and removal of pigmented lesions among the elderly population is forcing big companies to develop advanced treatment modules that deliver superior results and are cost-effective, thereby driving the market growth. Research and development in the pigment lesion treatment field have allowed big companies to manufacture non-invasive med-aesthetic systems to treat severe impacts of Pigmented lesions Treatments efficiently. Due to their comfort and effectiveness, these treatments rapidly gain popularity and trust among patients.The presence of well-established healthcare infrastructure for treating patients and existing market key players provide efficient treatment in patients with post-inflammatory hyperpigmentation. Moreover, factors such as growing aesthetic awareness and the regular ubiquity of pigmented lesions bolster the market demand over the review period. Chronic alcohol consumption habits, increasing adoption of synthetic cosmetic products, and new medications and treatments foster the need for pigmented lesions. 

MARKET RESTRAINTS

Simultaneously, the development of pigment devices has led to enhanced patient safety and has removed adverse side effects, which are estimated to hinder market growth. Adverse effects of laser treatments such as skin swelling, itching, and redness, along with chances of hyperpigmentation, scarring, blistering, and infections, are likely to be central in rare cases that may hinder the market growth. Lack of awareness regarding laser treatment and shortage of skilled professionals impede the pigmented lesion treatment market growth.

Impact of COVID-19 on the global pigmented lesion treatment market

The COVID-19 pandemic has shown a quantifiable impact on the economy, in turn on pigmented lesion treatment market. The drugs taken by the COVID-19 patients may have adverse effects on their skin, resulting in pigmentation. Governments have imposed guidelines to prevent the stoppage of the disease. The launch of new skincare products, drugs, and approvals have paused their activities as they face trading restrictions. During the lockdown period, patients haven't visited dermatologists to get their skin problems healed. Due to this, there was a slight decline in the healthcare economy around the world. Tele-consultations were more adopted meeting the patients virtually. After the lockdown had uplifted, the patients started visiting their skin specialists, following all the precautions for their safety. 

REPORT COVERAGE

SEGMENTAL ANALYSIS 

Global Pigmented Lesion Treatment Market Analysis By Product

The IPL devices segment accounted for the largest share of the market based on the product, followed by energy-based devices.The energy-based devices segment is expected to perform well in the global pigmented lesion treatment market. The segment growth is due to technological advancements in therapeutic techniques like the invention of new laser and energy-based treatments together with high-level equipment handling devices. The growing demand for treatment techniques with quick recovery, less pain, and post-treatment infections further increases market growth. 

Global Pigmented Lesion Treatment Market Analysis By End User

Based on end-user, the Dermatology segment is expected to dominate the end-user segment in revenue. Well-established healthcare infrastructure, skilled professionals, and specialists are driving the growth of this segment.

REGIONAL ANALYSIS

North America accounted for the largest share of the Pigmented Lesion Treatment market, followed by Europe and the Asia Pacific. It can be accredited to the growing awareness among consumers regarding accessibility to various Pigmented Lesion Treatment devices. Factors such as the widespread presence of leading market players in the region and the availability of advanced skin treatment techniques are key factors governing the market growth in this region. Besides, a large portion of the geriatric population in this region is increasingly opting for skincare therapies to enhance their look and reduce the risk of skin-related diseases.

KEY PLAYERS IN THE GLOBAL PIGMENTED LESION TREATMENT MARKET

Some of the most promising companies operating in the global pigmented lesion treatment market profiled in this report are Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.

RECENT HAPPENINGS IN THE MARKET

• In February 2019, Cutera Inc. announced the launch of the excel V+ laser platform. Excel V+ is a technology platform with more power and treatment speed in treating vascular and pigment lesions concerns. 

• In March 2018, Alma Lasers released PICO CLEAR's launch for varied skincare challenges in fewer treatments. PICO CLEAR offers an extensive range of skincare applications that include tattoo removal, benign pigmented lesions, acne scars, and wrinkles. PICO CLEAR is used for delivering ultra-sound picosecond pulses of energy into skin tissue, aiming for related pigment. 

• In June 2018, Lutronic's PICO PLUS system received U.S FDA approval. The PICO PLUS provides many offers that include pigment removal, rejuvenation, and laser facial toning. The FDA has approved the system to treat different types of pigment lesions and complex tattoo cases. 
• In March 2017, Synergy Medsales publicly announced its agreement with FormaTK systems. The deal is regarding their latest FDA-approved laser technology: “MAGMA," offering progress in treating pigmented lesions, photo-rejuvenation, and treatment of acne. 
• In July 2016, Syneron Medical received the FDA 510(K) clearance for its Pico Way Laser. The laser is ultra-short of 785nm wavelength, and Pico Way is an aesthetic laser system for treating pigmented lesions.

DETAILED SEGMENTATION OF THE GLOBAL PIGMENTED LESION TREATMENT MARKET

This market research report on the global pigmented lesion treatment market has been segmented and sub-segmented based on the product, end-user, and region.

By Product

• Energy-Based Devices

• RF Devices
• Ultrasound Devices
• IPL Devices

By End User

• Beauty Clinics

• Dermatology Clinics

By Region

• North America

• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa